PTC Therapeutics Inc (NASDAQ:PTCT)
| 22.41 Delayed Data As of Sep 29 |  -0.25 / -1.10%Today’s Change | 22.03 Today|||52-Week Range 59.84 | -41.29% Year-to-Date |
Latest PTCT News | Press Releases
| PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024 Sep 29 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains? Sep 20 / Zacks.com - Paid Partner Content |
| Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down Sep 21 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Down on Negative CHMP Opinion for DMD Drug Sep 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 22.66 |
| Today’s open | 22.94 |
| Day’s range | 22.24 - 23.35 |
| Volume | 35,219 |
| Average volume (3 months) | 928,134 |
| Market cap | $1.7B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -4.82% |
| Earnings growth (this year) | +46.38% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +29.75% |
| P/E ratio | NM |
| Price/Sales | 3.92 |
| Price/Book | -- |
Competitors
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | October 26, 2023 |
| EPS forecast (this quarter) | -$1.08 |
| Annual revenue (last year) | $698.8M |
| Annual profit (last year) | -$559.0M |
| Net profit margin | -80.00% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South Plainfield, New Jersey |
Forecasts
